|
[1]
|
Skin and the Heart
2021
DOI:10.1007/978-3-030-54779-0_22
|
|
|
|
|
[2]
|
The Many Faces of Itraconazole Cardiac Toxicity
Mayo Clinic Proceedings: Innovations, Quality & Outcomes,
2020
DOI:10.1016/j.mayocpiqo.2020.05.006
|
|
|
|
|
[3]
|
Safety of current therapies for onychomycosis
Expert Opinion on Drug Safety,
2020
DOI:10.1080/14740338.2020.1829592
|
|
|
|
|
[4]
|
Lack of Effect of Rezafungin on QT/QTc Interval in Healthy Subjects
Clinical Pharmacology in Drug Development,
2019
DOI:10.1002/cpdd.757
|
|
|
|
|
[5]
|
Antifungal activity and mechanism of heat-transformed ginsenosides from notoginseng against Epidermophyton floccosum, Trichophyton rubrum, and Trichophyton mentagrophytes
RSC Adv.,
2017
DOI:10.1039/C6RA27542G
|
|
|
|
|
[6]
|
Echinocandins in antifungal pharmacotherapy
Journal of Pharmacy and Pharmacology,
2017
DOI:10.1111/jphp.12780
|
|
|
|
|
[7]
|
Cardiotoxicity with Itraconazole
BMJ Case Reports,
2017
DOI:10.1136/bcr-2017-219376
|
|
|
|
|
[8]
|
Sinus bradycardia and chronotropic incompetence associated with single-agent itraconazole antifungal therapy: A case report
HeartRhythm Case Reports,
2015
DOI:10.1016/j.hrcr.2014.09.002
|
|
|
|
|
[9]
|
Cardiac response to centrally administered echinocandin antifungals
Journal of Pharmacy and Pharmacology,
2015
DOI:10.1111/jphp.12429
|
|
|
|
|
[10]
|
Growth Inhibition and Membrane Permeabilization ofCandida lusitaniaeUsing Varied Pulse Shape Electroporation
BioMed Research International,
2015
DOI:10.1155/2015/457896
|
|
|
|
|
[11]
|
Cardiac toxicity of some echinocandin antifungals
Expert Opinion on Drug Safety,
2014
DOI:10.1517/14740338.2013.829036
|
|
|
|
|
[12]
|
Cardiac toxicity of the echinocandins: chance or cause and effect association?
Journal of Clinical Pharmacy and Therapeutics,
2014
DOI:10.1111/jcpt.12108
|
|
|
|